Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Impact of autophagy inhibition on targeting imaging of allotransplantation with 125I-anti-TLR5

Shanshan Zhao, Guihua Hou and Ting Liang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1089;
Shanshan Zhao
2Biomedical isotope research center Shandong University Jinan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guihua Hou
2Biomedical isotope research center Shandong University Jinan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ting Liang
1Biomedical Isotope Research Center, Shandong Unive Ji Nan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1089

Objectives: It has been reported that TLR5 could radio-imaging allograft apparently, but whether Rapamycin (Rapa) activated autophagy affecting TLR5 targeting imaging is not clear. This study aimed to evaluate the effect of autophagy on TLR5-targeting imaging in allotransplantation mice model. Methods 125I-anti-TLR5 was prepared and identified according to reference we published previously. Rapa was used to induce tolerance along with autophagy activating and 3MA was used as autophagy inhibitor. Allotransplantation mice model were established and randomly divided into four groups: Control, Rapa, 3MA and Rapa plus 3MA. The autophagy expression was measured by Western Blot. The uptake and dissociation of 125I-anti-TLR5 with spleen cells of BALB/c mice was studied.125I-anti-TLR5 was injected through tail veins on day 9 post allotranplantation. Biodistribution and whole-body phosphor-autoradiography were performed. T/NT ratio (Target to non-target, graft/opposite muscle) and radioactivity activity ratio in vivo were analyzed. Histology and immunohistochemical staining of Beclin-1 and TLR5 were performed on day 12 post transplantation. Results 125I-anti-TLR5 was successfully prepared with 95.88% labeling rate and keep stable until 96h (89.04±1.16 % vs 87.44±0.58) in normal saline and serum. Autophagy molecules Beclin 1/ATG5 were increased after Rapa treated and decreased with 3MA administration. The uptake and dissociation of tracer was not apparently changed with the treatment of Rapa and/or 3MA compared with the Control. Biodistribution studies showed that 125I-anti-TLR5 were mainly metabolized through the liver and kidney, and the high radioactivity in grafted skin was detected. The T/NT ratio was significantly higher in group of Rapa (13.25±0.14 vs 4.32±0.21, P<0.01) and Rapa plus 3MA (6.460±0.15 vs 4.32±0.21, P<0.01) than Control. Whole body phosphor-screen auto-radioimaging showed clear skin grafts from 48h, and radioactivity activity ratio remarkably increased with Rapa application in 72h (Rapa 5.33±0.12; and Rapa plus 3MA groups 2.46±0.38 vs Control 1.46±0.20, P<0.01, P<0.01). Acute inflammatory infiltration in allograft was apparently decreased in groups of Rapa and Rapa+3MA. Both TLR5 and Beclin-1 positive staining were increased in Rapa and Rapa+3MA groups compared with the group of Control, and no obviously difference was detected between the groups of Rapa+3MA and Rapa alone. Conclusion TLR5 expression is higher under Rapa application, autophagy induced by Rapa showed no significant impact on 125I-anti-TLR5 targeted allograft imaging.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of autophagy inhibition on targeting imaging of allotransplantation with 125I-anti-TLR5
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of autophagy inhibition on targeting imaging of allotransplantation with 125I-anti-TLR5
Shanshan Zhao, Guihua Hou, Ting Liang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1089;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of autophagy inhibition on targeting imaging of allotransplantation with 125I-anti-TLR5
Shanshan Zhao, Guihua Hou, Ting Liang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1089;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Cardiovascular, Endocrine & Other Posters

  • Radiosynthesis of b-phenylethylamine derivatives for cardiac sympathetic nervous PET imaging
  • Feasibility and potentials of thymidine phosphorylase (TP) as an imaging biomarker and its nuclear medicine imaging for the diagnosis of non-alcoholic steatohepatitis
  • Synthesis and characterization of an 18F-labeled AmBF3-conjugated albumin-binding peptide for imaging blood pool by PET/CT
Show more Preclinical Probes for Cardiovascular, Endocrine & Other Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire